🇺🇸 FDA
Patent

US 9205088

Compositions of 1,2,4-oxadiazol benzoic acid compounds and methods for their use

granted A61KA61K31/4245A61K31/4439

Quick answer

US patent 9205088 (Compositions of 1,2,4-oxadiazol benzoic acid compounds and methods for their use) held by PTC THERAPEUTICS, INC. expires Mon Dec 03 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
PTC THERAPEUTICS, INC.
Grant date
Tue Dec 08 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 03 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
21
CPC classes
A61K, A61K31/4245, A61K31/4439, A61K31/454, A61K31/4545